ARJUNA Therapeutics
We are developing an entirely novel class of orally available small molecules to address untreatable cancers. Our first drug, Ag5, aims to redefine the treatment landscape for solid tumours on both s...load more
ARJUNA Therapeutics's Basic Information
Industry
Pharmaceutical Manufacturing
Founded Year
2019
ARJUNA Therapeutics's Competitors
Employee Insights
ARJUNA Therapeutics's Top Employees
Darren Bianchi
Co-Founder & Board Member
Phone Email
Charlie Sheppard
Co-Founder and Board Director Arjuna Therapeutics
Phone Email
Ross Breckenridge
Chief Executive Officer
Phone Email
Frequently Asked Questions Regarding ARJUNA Therapeutics
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts